PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 121 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $735,000 | -19.8% | 77,912 | -46.2% | 0.12% | -5.7% |
Q3 2016 | $917,000 | -63.7% | 144,902 | -67.2% | 0.12% | -69.2% |
Q3 2015 | $2,526,000 | -49.6% | 441,561 | -34.2% | 0.40% | -31.7% |
Q2 2015 | $5,008,000 | +62.2% | 671,331 | +30.0% | 0.59% | +64.1% |
Q1 2015 | $3,087,000 | -26.2% | 516,289 | -6.7% | 0.36% | -38.9% |
Q4 2014 | $4,183,000 | – | 553,309 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 1,583,925 | $8,007,000 | 1.48% |
Phocas Financial Corp. | 1,022,708 | $5,169,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,776,490 | $8,980,000 | 0.32% |
FARALLON CAPITAL MANAGEMENT LLC | 7,350,000 | $37,154,000 | 0.28% |
NEXPOINT ASSET MANAGEMENT, L.P. | 716,880 | $3,624,000 | 0.23% |
J. Goldman & Co LP | 499,698 | $2,526,000 | 0.19% |
PINNACLE ASSOCIATES LTD | 1,257,098 | $6,355,000 | 0.15% |
CARILLON TOWER ADVISERS, INC. | 3,948,024 | $19,957,000 | 0.14% |
EAGLE ASSET MANAGEMENT INC | 4,504,094 | $22,768,000 | 0.12% |
Worth Venture Partners, LLC | 32,956 | $167,000 | 0.10% |